BRPI0507912A - método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo - Google Patents
método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativoInfo
- Publication number
- BRPI0507912A BRPI0507912A BRPI0507912-8A BRPI0507912A BRPI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A
- Authority
- BR
- Brazil
- Prior art keywords
- increased bone
- treating
- individual suffering
- active compound
- therapeutically active
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 3
- 230000008416 bone turnover Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 229960003969 ospemifene Drugs 0.000 abstract 1
- LUMKNAVTFCDUIE-VHXPQNKSSA-N ospemifene Chemical compound C1=CC(OCCO)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 LUMKNAVTFCDUIE-VHXPQNKSSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940095743 selective estrogen receptor modulator Drugs 0.000 abstract 1
- 239000000333 selective estrogen receptor modulator Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/783,092 US20050187302A1 (en) | 2004-02-23 | 2004-02-23 | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
| PCT/FI2005/000034 WO2005079776A1 (en) | 2004-02-23 | 2005-01-19 | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0507912A true BRPI0507912A (pt) | 2007-07-10 |
Family
ID=34861145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0507912-8A BRPI0507912A (pt) | 2004-02-23 | 2005-01-19 | método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050187302A1 (enExample) |
| EP (1) | EP1718287A1 (enExample) |
| JP (1) | JP2007523209A (enExample) |
| CN (1) | CN1972680A (enExample) |
| AU (1) | AU2005215173A1 (enExample) |
| BR (1) | BRPI0507912A (enExample) |
| CA (1) | CA2557116A1 (enExample) |
| MX (1) | MXPA06009549A (enExample) |
| NO (1) | NO20064007L (enExample) |
| RU (1) | RU2006133903A (enExample) |
| WO (1) | WO2005079776A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
| WO2007092433A2 (en) * | 2006-02-06 | 2007-08-16 | Tethys Bioscience, Inc. | Osteoporosis associated markers and methods of use thereof |
| KR101510646B1 (ko) * | 2007-02-14 | 2015-04-10 | 호르모스 메디칼 리미티드 | 치료적으로 유용한 트리페닐부텐 유도체의 제조 방법 |
| US7504530B2 (en) * | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
| JP5010034B2 (ja) * | 2007-12-28 | 2012-08-29 | エフ．ホフマン−ラ ロシュ アーゲー | 生理学的状態の評価 |
| CN102690347B (zh) * | 2012-05-18 | 2014-06-25 | 北京北方生物技术研究所 | 分离i型前胶原氨基末端肽的方法 |
| EP2909164A1 (en) | 2012-10-19 | 2015-08-26 | Fermion Oy | A process for the preparation of ospemifene |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9418067D0 (en) * | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
-
2004
- 2004-02-23 US US10/783,092 patent/US20050187302A1/en not_active Abandoned
-
2005
- 2005-01-19 JP JP2007500232A patent/JP2007523209A/ja not_active Abandoned
- 2005-01-19 CA CA002557116A patent/CA2557116A1/en not_active Abandoned
- 2005-01-19 WO PCT/FI2005/000034 patent/WO2005079776A1/en not_active Ceased
- 2005-01-19 BR BRPI0507912-8A patent/BRPI0507912A/pt not_active IP Right Cessation
- 2005-01-19 CN CNA2005800049712A patent/CN1972680A/zh active Pending
- 2005-01-19 AU AU2005215173A patent/AU2005215173A1/en not_active Abandoned
- 2005-01-19 EP EP05708122A patent/EP1718287A1/en not_active Ceased
- 2005-01-19 RU RU2006133903/14A patent/RU2006133903A/ru not_active Application Discontinuation
- 2005-01-19 MX MXPA06009549A patent/MXPA06009549A/es unknown
-
2006
- 2006-09-06 NO NO20064007A patent/NO20064007L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1718287A1 (en) | 2006-11-08 |
| JP2007523209A (ja) | 2007-08-16 |
| WO2005079776A1 (en) | 2005-09-01 |
| NO20064007L (no) | 2006-09-21 |
| AU2005215173A8 (en) | 2009-09-24 |
| CA2557116A1 (en) | 2005-09-01 |
| AU2005215173A1 (en) | 2005-09-01 |
| US20050187302A1 (en) | 2005-08-25 |
| RU2006133903A (ru) | 2008-03-27 |
| CN1972680A (zh) | 2007-05-30 |
| MXPA06009549A (es) | 2007-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200602324A (en) | Tetrahydro-indazole cannabinoid modulators cross reference to related applications | |
| NO20061925L (no) | Farmasoytiske preparater for forebyggelse av overdose eller misbruk | |
| MX2007004936A (es) | Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1. | |
| MX2010006519A (es) | Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina. | |
| WO2005117870A3 (en) | Combination of proton pump inhibitor, buffering agent, and prokinetic agent | |
| WO2008115469A3 (en) | Role of hedgehog signaling in atherosclerosis and cardiovascular disease | |
| MX2009006339A (es) | Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide. | |
| WO2007098099A3 (en) | Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor | |
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| CL2008001782A1 (es) | Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion. | |
| NO20075801L (no) | Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose | |
| CL2009000803A1 (es) | Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| BRPI0718469A2 (pt) | Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto. | |
| BRPI0507645A (pt) | anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico | |
| BRPI0507912A (pt) | método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo | |
| BRPI0507626A (pt) | compostos e composiçoes como moduladores de lxr | |
| IL186356A0 (en) | Method of treating of preventing type-2 diabetes | |
| NO20100268L (no) | Anvendelse av gjaercellevegger til behandling og/eller forebygging av hyperinsulinemi | |
| IL174427A0 (en) | Transdermal no-generating agents for treating tendinopathy | |
| BRPI0508333A (pt) | uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit | |
| ZA200709048B (en) | Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse | |
| ECSP088314A (es) | Moduladores de cannabinoides hexahidro-cicloheptapirazol | |
| UY30557A1 (es) | Tratamiento y prevencion de la fibrosis intestinal | |
| MX2007007206A (es) | Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: RFERENTE A 3A E 6A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011. |